Pharmaceuticals & Therapeutics

As Northstar Clean Technologies nears a key production milestone and expands to the U.S., its latest financials reveal a classic cleantech dilemma: a widening loss.

A novel drug for muscle loss in COPD patients has fully recruited its Phase 2 trial, a major step towards the first-ever treatment for sarcopenia.

New long-term data on pegcetacoplan offers significant hope for patients with rare, debilitating kidney diseases, strengthening Sobi's market position.

Haisco's Cipepofol gains US FDA approval, challenging Propofol with enhanced safety and signaling a new era of Chinese pharmaceutical innovation.

With strong data for volixibat, brelovitug, and LIVMARLI, Mirum (MIRM) de-risks its pipeline and sets the stage for growth. Here's the analysis.

In eastern Croatia, a drone powerhouse and a green packaging firm are 20 mins apart. Their local synergy is rewriting the rules for sustainable defense logistics.

Cumberland Pharmaceuticals and SciClone launch Vibativ in China, offering a new defense against deadly, drug-resistant bacteria in a high-stakes market.

The supplement maker's top-tier safety certification and recent acquisition signal a strategic push for market dominance and unparalleled consumer trust.

A new report reveals the staggering financial and human cost of treatment-resistant depression, highlighting massive gaps in patient and caregiver support.

Dwayne Johnson's PAPATUI launches a prestige cologne line at Target. With top perfumers and a $40 price, can it redefine men's luxury?

Groundbreaking research on new drug classes, the gut-brain axis, and personalized medicine will be unveiled at the upcoming American Headache Society meeting.

Therini Bio's novel drug THN391 enters trials, targeting inflammation in diabetic eye disease, while a next-gen combo therapy aims to redefine care.

The 'It's Always Sunny' creators' Four Walls whiskey partners with Jesse Bongiovi's Lily Pond Group, aiming to scale with celebrity power and cultural savvy.

Sensorium Therapeutics advances SNTX-2643, a novel anxiety drug, while adding a new CMO and an expert advisory board to guide its clinical journey.

A new partnership between biotech leader Debut and Amazonian expert Natura aims to revolutionize anti-aging skincare with AI-discovered ingredients.

As a national estrogen patch shortage leaves women scrambling, a 90-day vaginal ring is emerging as a stable alternative in a disrupted HRT market.

ITG Brands acquires innovator Black Buffalo for $150M, diversifying beyond nicotine pouches to capture a new segment of smokeless alternative users.

Positive Phase 3 data for oral drug filgotinib offers new hope for thousands of axial spondyloarthritis patients who fail to respond to current therapies.

A lawsuit has been filed against The Kebab Shop after a severe E. coli outbreak left a child with kidney failure, placing the chain and its supplier under fire.

As fatal opioid overdoses triple, a new mobile treatment clinic arrives in Ellensburg, offering a crucial lifeline and eliminating a major barrier to care.